efeitos da inibição do sistema renina-angiotensina-aldosterona e do ...

FRANTZ, L.P.et al. Carvedilol therapy is associated with a sustained decline in brain
natriurético peptide levels in patients with congestive heart failure. Am Heart J, London,
v.149: p.541-7, 2005.
FREEDMAN, N.J.; LEFKOWITZ, R.J. Antiß1-adrenergic receptor antibodies and heart
failure: causation, not just correlation. J Clin Invest, Thorofare, v.113: p.1379-1382, 2004.
FREITAS, H. et al. β-Blockers for Chagas`s Heart disease: the reduction in heart rate may
not be associated to improvement in left ventricular ejection fraction and remodeling
process. JACC, New York, Abstracts 184 A – Heart Failure, 1999.
FU, L.X. Ant- M2 muscarinic receptor autoantibodies and idiopatic dilated
cardiomyopathy. Int J Cardiol, Sidney, v.54: p.127-135, 1996.
GEIC - Grupo de Estudos de Insuficiência Cardíaca; Sociedade Brasileira de Cardiologia.
Revisão das II Diretrizes da Sociedade Brasileira de Cardiologia para o Diagnóstico e
Tratamento da Insuficiência Cardíaca. Arq Bras Cardiol, São Paulo, v.79: p.IV:1-30,
2002.
GHEORGHIADE, M.; BONOW, R.O. Introduction and overview: beta-blocker therapy in
the management of chronic heart failure. Am J Med, New York, v.110(suppl 7A): p.1S-
5S, 2001.
GIL, P. et al. Cardio-renal insufficiency: the search for management strategies.
Curr Opin Nephrol Hypertens, Philadelphia, v.14;n.5: p.442-7, Sept 2005.
GOIN, J.C. et al. Identification of antibodies with muscarinic cholinergic activity in
human Chagas' disease. J Auton Nerv Syst, [s.l.], v.47: p.45-52. Abstract, 1994.
GOIN, J.C. et al. Interaction of human chagasic IgG with the second extracellular loop of
the human heart muscarinic acetylcholine receptor: functional and pathological
implications. FASEB J, [s.l.], v.11: p.77–83, 1997.
GUIMARÃES, A.C. Aspectos eletrocardiográficos da cardiopatia crônica. Cardiopatia
chagásica. Cançado JR, Chuster M. Fundação Carlos Chagas, Belo Horizonte, v.16:
p.141-155, 1985.
HALLSWORTH, M.P. et al. β2 adrenoceptor agonists inhibit release of eosinophilactivating
cytokines from human airway smooth muscle cells. British Journal of
Pharmacology, London, v.132: p.729-741, 2001.
HIGUCHI, M.L. et al. Pathophysiology of the heart in Chagas’ disease: current status and
new developments. Cardiovascular Research; London, v.60: p.96-107, 2003.
HUNT, S.A.; GIBBONS, R.J.; ANTMAN, E.M. ACC/AHA Guidelines for the evaluation
and management of chronic heart failure in the adult. ACC/AHA Pratice Guidelines,
[s.l.], 2001.
HUNT, S.A. et al. Guideline update for the diagnosis and management of chronic heart
failure in the adult: a report of the American College of Cardiology/American Heart
131